The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

The average age of men who get diagnosed is 67.

Slated for March 12, The Dana-Farber Cancer Institute's Breakfast with the Doctors will feature a discussion between five ...

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

COLUMBUS, Ohio (WCMH) — A new study from The James Cancer Hospital at Ohio State is showing promising results for improving ...

Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...

Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver ...

The trust that runs the major hospitals in Shropshire is taking part in a new lung cancer study to find alternative ...